Research Assistant: AI-Driven Peptide Design for Cancer

Karolinska Institutet; Solna kommun; On-site; SEK 420,000 - 560,000; Full time

Job summary

Karolinska Institutet in Solna invites a motivated candidate for a one-year Research Assistant role focusing on AI-driven peptide design and translational cancer research at Science for Life Laboratory.

The successful candidate will work in a multidisciplinary team applying computational methods and experimental validation to advance cancer therapeutics, with a strong emphasis on translational potential and scientific communication.

Qualifications

• University degree in medicine/biomedicine or related field.
• At least one year of research experience in cancer biology or related field.
• Ability to evaluate clinical and experimental evidence for targets and translational potential.
• Experience in molecular and cellular biology and data analysis.
• Fluency in English (written and spoken).
• Clinical exposure to oncology/hematology preferred.
• Experience contributing to clinical study applications or translation efforts.
• Familiarity with protein interactions, structural biology, computational drug discovery, or AI-assisted design.

Responsibilities

• Conduct hands-on AI-driven peptide design experiments.
• Collaborate on translational cancer research projects.
• Prepare manuscripts, presentations, and grant-related documents.

Skills

English communication

Research experience

Molecular & cellular biology

Clinical study translation

Scientific communication

Education

University degree in medicine/biomedicine

Tools

Protein–protein interactions

Structural biology

Computational drug discovery

AI-assisted design

Job description

Karolinska Institutet in Solna invites a motivated candidate for a one-year Research Assistant role focusing on AI-driven peptide design and translational cancer research at Science for Life Laboratory.

The successful candidate will work in a multidisciplinary team applying computational methods and experimental validation to advance cancer therapeutics, with a strong emphasis on translational potential and scientific communication.